RxDoctor Payments Data

Trystan Crook, DO

Family Medicine · Overland Park, KSNPI 1437146214

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 953 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,912in general payments, 2019–2025

Across 953 payments — averaging $15.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Lilly USA, LLC$1K
  • Novo Nordisk$1K
  • Amgen$965
  • Boehringer Ingelheim$859
  • Pfizer$698
  • plus $7K from 54 others

What the payments were for

  • Food & beverage$14,912100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)164$2,627
Lilly USA, LLC86$1,465
Novo Nordisk107$1,307
Amgen56$965
Boehringer Ingelheim47$859
Pfizer67$698
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC45$652
AstraZeneca39$618
Merck33$435
Antares Pharma, Inc.22$416
Otsuka America Pharmaceutical, Inc.18$380
Novartis21$303
Teva Pharmaceuticals USA, Inc.18$272
GSK17$242
Takeda Pharmaceuticals U.S.A., Inc.15$236
Abbott12$233
Biohaven Pharmaceutical Holding Company Ltd.15$227
Corium, LLC13$199
Johnson & Johnson13$190
Bayer9$172
Eisai Inc.9$151
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)7$142
Amarin Pharma, Inc.8$142
Sanofi-aventis U.S. LLC8$140
Axsome Therapeutics, Inc.7$134
Astellas Pharma US Inc7$126
Phathom Pharmaceuticals, Inc.8$125
Exeltis, USA Inc.4$95
Hologic Sales And Service, LLC5$92
IBSA Pharma Inc.5$86
Sumitomo Pharma America, Inc.4$84
Cranial Technologies, Inc5$81
Biohaven Pharmaceuticals, Inc.4$78
Clarus Therapeutics Inc.4$75
Currax Pharmaceuticals LLC5$68
Dexcom, Inc.3$51
Biogen2$49
Tolmar, Inc.3$45
Shield Therapeutics Inc2$43
Shire North American Group Inc3$36
Ardelyx, Inc.2$35
Bausch Health US, LLC2$35
Halozyme Inc2$35
Neos Therapeutics, LP2$34
Esperion Therapeutics, Inc.2$33
Braintree Laboratories, Inc.2$32
Forte Bio-pharma LLC2$31
Gilead1$28
Upsher-smith Laboratories LLC1$28
Agile Therapeutics, Inc.1$23
Idorsia Pharmaceuticals US Inc1$22
Ascendis Pharma Endocrinology Inc1$22
Arbor Pharmaceuticals, Inc.1$20
Apria Healthcare LLC1$18
E.r. Squibb & Sons, L.L.C.1$17
Roche Diagnostics Corporation1$17
Genentech USA, Inc.1$17
Valencia Technologies Corporation1$16
Misonix Inc1$15
Corcept Therapeutics1$14

How this compares

$14,912 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$28,783
Medicare patients
119
Services billed
9,502

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin27$37,081
OzempicSemaglutide13$9,665
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$7,116
Atorvastatin Calcium211$1,231
Ezetimibe23$623
Rosuvastatin Calcium34$514
Losartan Potassium43$438
Fluticasone Propionate15$434
Tamsulosin Hcl55$374
Lisinopril114$363
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen21$356
Levothyroxine Sodium74$337
Omeprazole21$271
Amlodipine Besylate81$267
ValacyclovirValacyclovir Hcl17$265

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$859$37,08127 claims
Novo NordiskOzempic$1,307$9,66513 claims
GSKTrelegy Ellipta$242$7,11611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Overland Park

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →